公司資料
Surrozen 股價、新聞與催化劑
- 股票代碼:
- SRZN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
23.99 USD (+2.09%)
收盤價
最後更新: 2026年8月21日
269M USD
市值
股價為何變動
As of Aug 21, 2026, SRZN closed up 2.09% at $23.99. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Surrozen is a biotechnology company focused on tissue regeneration and organ repair through Wnt biology. Its story centers on whether developmental biology can be translated into therapies for difficult diseases.
所在地與產業分類
Surrozen is headquartered in the United States and listed on NASDAQ. It sits in the regenerative and platform-biotech segment.
商業模式特徵
The company depends on translational science, platform validation, and the ability to keep a narrow pipeline funded while it develops its biology. Investors watch early data, strategic changes, and financing needs.
生技產業定位
Surrozen occupies a specialized regenerative-biology niche within biotech. The stock is sensitive to whether its platform can move beyond concept toward clinical relevance.
未來催化劑
- Surrozen’s catalysts are Wnt-biology programs and any update that shows the regenerative-medicine platform can still advance. The company is still early and data-dependent.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。